Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 09:34 am Purchase | 2022-12-31 | 13G | Mirati Therapeutics, Inc. MRTX | Avoro Capital Advisors LLC | 5,555,555 9.600% | 480,555 (+9.47%) | Filing History |
| 2023-02-14 09:33 am Purchase | 2022-12-31 | 13G | Krystal Biotech, Inc. KRYS | Avoro Capital Advisors LLC | 1,410,000 5.500% | 1,410,000 (New Position) | Filing History |
| 2023-02-14 09:33 am Purchase | 2022-12-31 | 13G | Ascendis Pharma A/S ASND | Avoro Capital Advisors LLC | 3,100,000 5.400% | 3,100,000 (New Position) | Filing History |
| 2023-02-14 09:32 am Sale | 2022-12-31 | 13G | Kura Oncology, Inc. KURA | Avoro Capital Advisors LLC | 3,105,000 4.500% | -895,000 (-22.38%) | Filing History |
| 2023-02-14 09:32 am Purchase | 2022-12-31 | 13G | DICE Therapeutics, Inc. DICE | Avoro Capital Advisors LLC | 2,525,555 5.300% | 2,525,555 (New Position) | Filing History |
| 2023-02-14 09:31 am Sale | 2022-12-31 | 13G | Iovance Biotherapeutics, Inc. IOVA | Avoro Capital Advisors LLC | 7,020,000 4.400% | -1,655,000 (-19.08%) | Filing History |
| 2023-02-14 09:30 am Sale | 2022-12-31 | 13G | Adverum Biotechnologies, Inc. ADVM | Avoro Capital Advisors LLC | 0 0.000% | -695,000 (Position Closed) | Filing History |
| 2022-09-26 5:27 pm Purchase | 2022-09-22 | 13D | Whitehawk Therapeutics Inc WHWK | Avoro Capital Advisors LLC | 3,471,752 14.400% | 1,260,000 (+56.97%) | Filing History |
| 2022-02-11 10:09 am Unchanged | 2021-12-31 | 13G | POINT Biopharma Global Inc. PNT | Avoro Capital Advisors LLC | 0 0.000% | 0 (Unchanged) | Filing History |
| 2022-02-11 10:08 am Sale | 2021-12-31 | 13G | Relmada Therapeutics, Inc. RLMD | Avoro Capital Advisors LLC | 0 0.000% | -1,525,000 (Position Closed) | Filing History |
| 2022-02-11 10:08 am Sale | 2021-12-31 | 13G | Fennec Pharmaceuticals Inc. FENC | Avoro Capital Advisors LLC | 1,200,000 4.600% | -470,000 (-28.14%) | Filing History |
| 2022-02-11 10:07 am Sale | 2021-12-31 | 13G | Avadel Pharmaceuticals plc AVDL | Avoro Capital Advisors LLC | 1,670,000 2.900% | -2,695,000 (-61.74%) | Filing History |
| 2022-02-11 10:07 am Sale | 2021-12-31 | 13G | Arena Pharmaceuticals, Inc. ARNA | Avoro Capital Advisors LLC | 1,235,000 2.000% | -2,955,000 (-70.53%) | Filing History |
| 2022-02-11 10:06 am Sale | 2021-12-31 | 13G | PMV Pharmaceuticals, Inc. PMVP | Avoro Capital Advisors LLC | 1,465,000 3.200% | -885,267 (-37.67%) | Filing History |
| 2022-02-11 10:06 am Purchase | 2021-12-31 | 13G | Monte Rosa Therapeutics, Inc. GLUE | Avoro Capital Advisors LLC | 3,311,434 7.100% | 3,311,434 (New Position) | Filing History |
| 2022-02-11 10:05 am Purchase | 2021-12-31 | 13G | Amicus Therapeutics, Inc. FOLD | Avoro Capital Advisors LLC | 18,500,000 6.600% | 7,300,000 (+65.18%) | Filing History |
| 2022-02-11 10:05 am Purchase | 2021-12-31 | 13G | IO Biotech, Inc. IOBT | Avoro Capital Advisors LLC | 2,055,883 7.100% | 2,055,883 (New Position) | Filing History |
| 2022-02-11 10:04 am Purchase | 2021-12-31 | 13G | Apellis Pharmaceuticals, Inc. APLS | Avoro Capital Advisors LLC | 8,555,555 8.900% | 8,555,555 (New Position) | Filing History |
| 2022-02-11 10:04 am Purchase | 2021-12-31 | 13G | Iovance Biotherapeutics, Inc. IOVA | Avoro Capital Advisors LLC | 8,675,000 5.500% | 1,175,000 (+15.67%) | Filing History |
| 2022-02-11 10:03 am Purchase | 2021-12-31 | 13G | Madrigal Pharmaceuticals, Inc. MDGL | Avoro Capital Advisors LLC | 1,425,000 8.300% | 200,000 (+16.33%) | Filing History |